MedTrace Logo

Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients

NCT02272244 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-05-04

Study results available
· View outcomes & findings →

Summary

This study is designed to test a standard mailed intervention (SI) versus a novel decision support and navigation intervention (DSNI). Working with patients and stakeholders, this randomized trial will include 400 Hispanic men and women who are 50 to 75 years of age, patients in community based primary care practices, and are eligible for CRC screening. We will consent, survey, and randomize participants either to the SI Group (n=200) or the DSNI Group (n=200). Study specific aims are to: (1) Assess intervention (DSNI versus SI) impact on overall CRC screening adherence; (2)Assess intervention (DNSI versus SI) impact on CRC screening decision stage; (3) Assess intervention (DNSI versus SI) impact on test-specific CRC screening adherence; and (4) Assess intervention (DNSI versus SI) impact on CRC and knowledge and perceptions.

Conditions

Interventions

BEHAVIORAL

Decision Support & Navigation

BEHAVIORAL

Standard

Sponsors & Collaborators

  • Lehigh Valley Hospital

    collaborator OTHER

  • Fox Chase Cancer Center

    collaborator OTHER

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Ronald E Myers, PhD · Thomas Jefferson University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-01
Primary Completion
2017-01-20
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02272244 on ClinicalTrials.gov